STeleR study: Telerehab improves functioning after stroke

May 29, 2012 in Cardiology

Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR, a home telerehabilitation program that they report improves lower body physical functioning after a stroke. Participating in STeleR also increased the likelihood of maintaining a regular fitness routine, enhanced money management skills, and improved the capability to prepare meals and take care of personal needs such as bathing.

"Effects of Telerehabilitation on Physical Function and Disability for " appears online ahead of print publication in the August issue of the journal Stroke.

"We know that post-stroke rehab is critically important," said Dr. Chumbler, a medical sociologist who chairs the Department of Sociology and directs the Institute for Research on Social Issues in the School of Liberal Arts at Indiana University-Purdue University Indianapolis. "But for many veterans and others who experience a stroke, participating in supervised rehab can be difficult because they live far from a rehab facility. Even if distance isn't an impediment, getting someone to provide transportation may not be easy. Providing rehab in the home is costly, and the availability of qualified physical or may be limited, particularly in rural areas.

"We found that stroke survivors will participate in and can benefit from a telehealth system that enables therapists to deliver and monitor rehab in the patient's home from a remote location."

The 52 veterans in the multi-site study received care from VA medical centers in Atlanta, Durham, N.C., and Tampa, Fla.; were predominantly male; were ethnically diverse; and had an average age of 67. Each had experienced an ischemic or within the previous two years and lived in the community rather than in an institution. The were randomized to usual care or the STeleR (short for stroke telerehab) intervention.

Three hourlong visits were made to the homes of those in the intervention arm of the study, during which a study team member used a camcorder to record physical and functional performance as well as discussed the home environment with the survivor. An in-home messaging device that looks like a clock radio and plugs into a telephone line was installed and monitored weekly by a teletherapist who responded after reviewing information entered by the study patients. Over the three-month period, telephone calls between the teletherapist and the patient took place biweekly. Both STeleR and usual care group participants received routine VA care as directed by their health care providers.

Most of the gains in physical functioning and other improvements occurred during the initial three months of the study but were maintained during the subsequent three months during which no STeleR services were provided.

"STeleR has potential to be a useful supplement to traditional post-stroke rehabilitation, given the limited resources available for in-home rehabilitation for ," Dr. Chumbler said. "STeleR or a similar telehealth program could be an important way to overcome access barriers and may be particularly useful for reaching vulnerable patient groups, such as individuals from a lower socioeconomic status and those who live in a rural area."

Journal reference: Stroke search and more info website

Provided by Indiana University School of Medicine search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 8 hours ago | popularity 5 / 5 (1) | comments 0

Post-approval TAVI registry shows high rates of device success at one year

One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...

Cardiology created 9 hours ago | popularity not rated yet | comments 0

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Cardiology created 10 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Study identifies superior hypertension treatment, efficacy between sexes

(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...

Cardiology created 18 hours ago | popularity 5 / 5 (1) | comments 0

Evaluating a new way to open clogged arteries

Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...

Cardiology created 18 hours ago | popularity 4.6 / 5 (5) | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.